Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Nabilone

Base Information Edit
  • Chemical Name:Nabilone
  • CAS No.:51022-71-0
  • Molecular Formula:C24H36O3
  • Molecular Weight:372.54
  • Hs Code.:
  • European Community (EC) Number:637-087-5
  • UNII:2N4O9L084N
  • DSSTox Substance ID:DTXSID8023341,DTXSID401015800
  • Nikkaji Number:J335.978F
  • Wikipedia:Nabilone
  • NCI Thesaurus Code:C1171
  • RXCUI:31447
  • Pharos Ligand ID:LNU79R715U7P,LNUYWYV8LRBX
  • Metabolomics Workbench ID:42831
  • ChEMBL ID:CHEMBL947
  • Mol file:51022-71-0.mol
Nabilone

Synonyms:Cesamet;Lilly 109514;LY 109514;nabilone;nabilone, (6aR-trans)-isomer;nabilone, (6aS-trans)-isomer;nabilone, (cis-(+-))-isomer;nabilone, (trans-(+-))-isomer

 This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

Chemical Property of Nabilone Edit
Chemical Property:
  • Appearance/Colour:White solid 
  • Vapor Pressure:5.52E-09mmHg at 25°C 
  • Melting Point:155-156°C 
  • Refractive Index:1.516 
  • Boiling Point:457.4 °C at 760 mmHg 
  • PKA:pKa in 66% DMF: 13.5(at 25℃) 
  • Flash Point:145.4 °C 
  • PSA:46.53000 
  • Density:1.029 g/cm3 
  • LogP:6.26400 
  • Storage Temp.:2-8°C 
  • Solubility.:DMSO: ~18 mg/mL, soluble 
  • XLogP3:6.4
  • Hydrogen Bond Donor Count:1
  • Hydrogen Bond Acceptor Count:3
  • Rotatable Bond Count:6
  • Exact Mass:372.26644501
  • Heavy Atom Count:27
  • Complexity:524
Purity/Quality:
Safty Information:
  • Pictogram(s): HarmfulXn 
  • Hazard Codes:Xn,F 
  • Statements: 22-36-20/21/22-11 
  • Safety Statements: 36/37/39-45-36/37-16 
MSDS Files:

SDS file from LookChem

Total 1 MSDS from other Authors

Useful:
  • Drug Classes:Gastrointestinal Agents
  • Canonical SMILES:CCCCCCC(C)(C)C1=CC(=C2C3CC(=O)CCC3C(OC2=C1)(C)C)O
  • Isomeric SMILES:CCCCCCC(C)(C)C1=CC(=C2[C@@H]3CC(=O)CC[C@H]3C(OC2=C1)(C)C)O
  • Recent ClinicalTrials:Multimodal Assessment of Cannabinoid Target Engagement in Adults With Obsessive-Compulsive Disorder
  • Recent EU Clinical Trials:Nabilone for non-motor symptoms in Parkinson’s disease: An open-label study to evaluate long-term safety and efficacy
  • Uses A labelled synthetic cannabinoid with antiemetic, antiglaucoma, and CNS activity. Antiemetic. Controlled substance (hallucinogen). A synthetic cannabinoid with antiemetic, antiglaucoma, and CNS activity. Antiemetic. Controlled substance (hallucinogen).
  • Clinical Use Synthetic cannabinoid: Treatment of nausea and vomiting due to chemotherapy
  • Drug interactions Potentially hazardous interactions with other drugs Use with caution with other psychoactive medication or CNS depressants